UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting

Pharmaceutical research, 2022-10, Vol.39 (10), p.2507-2514

2022

Volltextzugriff (PDF)

A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer

Cancer, 2024-03, Vol.130 (5), p.683-691

2024

Volltextzugriff (PDF)

A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments

Cancer treatment reviews, 2023-11, Vol.120, p.102628-102628, Article 102628

2023

Volltextzugriff (PDF)

Pharmacotherapy for treatment of lung cancer in the elderly

Expert opinion on pharmacotherapy, 2015-05, Vol.16 (7), p.1021-1034

2015

Volltextzugriff (PDF)

Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy

Histopathology, 2011-10, Vol.59 (4), p.692-702

2011

Volltextzugriff (PDF)

A reply to “Comment on: ‘Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer”

Lung cancer (Amsterdam, Netherlands), 2020-10, Vol.148, p.181-181

2020

Volltextzugriff (PDF)

High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial

Lung cancer (Amsterdam, Netherlands), 2022-08, Vol.170, p.133-140

2022

Volltextzugriff (PDF)

Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion–Positive Advanced NSCLC

Journal of thoracic oncology, 2018-08, Vol.13 (8), p.1222-1226

2018

Volltextzugriff (PDF)

Interim results of a phase II single arm trial combining afatinib with cetuximab in patients with EGFRex20ins positive NSCLC

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9112-9112

2021

Volltextzugriff (PDF)

Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses

Lung cancer (Amsterdam, Netherlands), 2018-10, Vol.124, p.130-134

2018

Volltextzugriff (PDF)

Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer

JCO precision oncology, 2019-03 (3), p.1-14

2019

Volltextzugriff (PDF)

Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy: Extraprostatic extension in prostate cancer

Histopathology, 2011-10, Vol.59 (4), p.692-702

2011

Volltextzugriff (PDF)

High Dose Osimertinib in Patients with Advanced Stage EGFR Exon 20 Mutation-Positive NSCLC: Results from the Phase 2 Multicenter POSITION20 Trial

SSRN Electronic Journal

Volltextzugriff (PDF)

Photophysical studies of m-terphenyl-sensitized visible and near-infrared emission from organic 1∶1 lanthanide ion complexes in methanol solutions

Journal of the Chemical Society, Perkin Transactions 2, 1998 (10), p.2141-2150

1998

Volltextzugriff (PDF)

Van oorlog naar vrede: Bevrijding van echtscheidingstrauma met emdr

Kind en adolescent praktijk, 2013-12, Vol.12 (4), p.168-176

2013

Volltextzugriff (PDF)

New Building Blocks for the Noncovalent Assembly of homo- and hetero-Multinuclear Metallodendrimers

Organometallics, 1997-09, Vol.16 (20), p.4287-4291

1997

Volltextzugriff (PDF)

Self-assembly of hyperbranched spheres; correlation between monomeric synthon and sphere size

Chemical communications (Cambridge, England), 1997 (1), p.9-10

1997

Volltextzugriff (PDF)

Novel Preorganized Hemispherands To Encapsulate Rare Earth Ions: Shielding and Ligand Deuteration for Prolonged Lifetimes of Excited Eu 3+ Ions

Journal of the American Chemical Society, 1997-01, Vol.119 (1), p.138-144

1997

Volltextzugriff (PDF)

Novel Preorganized Hemispherands To Encapsulate Rare Earth Ions: Shielding and Ligand Deuteration for Prolonged Lifetimes of Excited Eu3+ Ions

Journal of the American Chemical Society, 1997-01, Vol.119 (1), p.138-144

1997

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(19)

Sprache

Englisch
(18)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(10)
Oncology
(7)
Chemistry
(5)
Physical Sciences
(5)
Humans
(4)
Nsclc
(4)
Respiratory System
(4)
Aged
(3)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(3)
Chemistry, Multidisciplinary
(3)
Lung Neoplasms - Drug Therapy
(3)
Mutation
(3)
Afatinib
(2)
Carcinoma, Non-Small-Cell Lung - Genetics
(2)
Cetuximab
(2)
Chemistry, Organic
(2)
Egfr Exon 20 Insertion
(2)
Epidermal Growth Factor Receptors
(2)
Erbb Receptors - Genetics
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Exposure–Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life Setting

A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer

A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments

Pharmacotherapy for treatment of lung cancer in the elderly

Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy

A reply to “Comment on: ‘Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer”

High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial

Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion–Positive Advanced NSCLC

Interim results of a phase II single arm trial combining afatinib with cetuximab in patients with EGFRex20ins positive NSCLC

Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responses

Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer

Quantification of extraprostatic extension in prostate cancer: different parameters correlated to biochemical recurrence after radical prostatectomy: Extraprostatic extension in prostate cancer

High Dose Osimertinib in Patients with Advanced Stage EGFR Exon 20 Mutation-Positive NSCLC: Results from the Phase 2 Multicenter POSITION20 Trial

Photophysical studies of m-terphenyl-sensitized visible and near-infrared emission from organic 1∶1 lanthanide ion complexes in methanol solutions

Van oorlog naar vrede: Bevrijding van echtscheidingstrauma met emdr

New Building Blocks for the Noncovalent Assembly of homo- and hetero-Multinuclear Metallodendrimers

Self-assembly of hyperbranched spheres; correlation between monomeric synthon and sphere size

Novel Preorganized Hemispherands To Encapsulate Rare Earth Ions: Shielding and Ligand Deuteration for Prolonged Lifetimes of Excited Eu 3+ Ions

Novel Preorganized Hemispherands To Encapsulate Rare Earth Ions: Shielding and Ligand Deuteration for Prolonged Lifetimes of Excited Eu3+ Ions

Suchergebnisse filtern